Evidence map›Paper›PMID 37568632›Full record

ArticleCancers2023

G4-QuadScreen: A Computational Tool for Identifying Multi-Target-Directed Anticancer Leads against G-Quadruplex DNA.

Jyotsna Bhat-Ambure, Pravin Ambure, Eva Serrano-Candelas, Cristina Galiana-Roselló, Ariadna Gil-Martínez, Mario Guerrero, Margarita Martin, Jorge González-García, Enrique García-España, Rafael Gozalbes

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jyotsna Bhat-AmbureMolDrug AI Systems SL, c/Olimpia Arozena Torres, 46018 Valencia, Spain.ORCID 0000-0002-1500-7040
Pravin AmbureProtoQSAR SL, Centro Europeo de Empresas Innovadoras (CEEI), Parque Tecnológico de Valencia, 46980 Valencia, Spain.
Eva Serrano-CandelasProtoQSAR SL, Centro Europeo de Empresas Innovadoras (CEEI), Parque Tecnológico de Valencia, 46980 Valencia, Spain.ORCID 0000-0002-8929-5364
Cristina Galiana-RosellóDepartment of Inorganic Chemistry, Institute of Molecular Science, University of Valencia, 46980 Valencia, Spain.ORCID 0000-0003-1365-1323
Ariadna Gil-MartínezDepartment of Inorganic Chemistry, Institute of Molecular Science, University of Valencia, 46980 Valencia, Spain.
Mario GuerreroBiochemistry and Molecular Biology Unit, Biomedicine Department, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.
Margarita MartinBiochemistry and Molecular Biology Unit, Biomedicine Department, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-9245-4899
Jorge González-GarcíaDepartment of Inorganic Chemistry, Institute of Molecular Science, University of Valencia, 46980 Valencia, Spain.ORCID 0000-0001-8994-1779
Enrique García-EspañaDepartment of Inorganic Chemistry, Institute of Molecular Science, University of Valencia, 46980 Valencia, Spain.
Rafael GozalbesMolDrug AI Systems SL, c/Olimpia Arozena Torres, 46018 Valencia, Spain.
Universitat de València · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study presents 'G4-QuadScreen', a user-friendly computational tool for identifying MTDLs against G4s. Also, it offers a few hit MTDLs based on in silico and in vitro approaches. Multi-tasking QSAR models were developed using linear discriminant analysis and random forest machine learning techniques for predicting the responses of interest (G4 interaction, G4 stabilization, G4 selectivity, and cytotoxicity) considering the variations in the experimental conditions (e.g., G4 sequences, endpoints, cell lines, buffers, and assays). A virtual screening with G4-QuadScreen and molecular docking using YASARA (AutoDock-Vina) was performed. G4 activities were confirmed via FRET melting, FID, and cell viability assays. Validation metrics demonstrated the high discriminatory power and robustness of the models (the accuracy of all models is ~>90% for the training sets and ~>80% for the external sets). The experimental evaluations showed that ten screened MTDLs have the capacity to selectively stabilize multiple G4s. Three screened MTDLs induced a strong inhibitory effect on various human cancer cell lines. This pioneering computational study serves a tool to accelerate the search for new leads against G4s, reducing false positive outcomes in the early stages of drug discovery. The G4-QuadScreen tool is accessible on the ChemoPredictionSuite website.

Indexed as

cancerdrug designFID assaysFRET experimentsG4 quadruplexmolecular dockingMTT assaysmulti-tasking QSARvirtual screening

Identifiers

PMID37568632
PMCPMC10416877
OpenAlexW4385346653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.